| CAS登錄號 | 中文名 | 英文名 | 分子結(jié)構(gòu)式 | 分子式 | 詳情 | 供應(yīng)商 |
| 65899-73-2 | 噻康唑; 1-[2-[(2-氯-3-噻吩甲氧基)]-2-(2,4-二氯苯基基)]乙基咪唑 | Tioconazole; 1-[2-[(2-Chlorothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)-ethyl]imidazole; Vagistat |  | C16H13Cl3N2OS | 詳情 | 供應(yīng)商 |
| 99592-32-2 | 硝酸舍他康唑; 1-[2-(7-氯苯并[b]噻吩-3-基)甲氧基-2-(2,4-二氯苯)乙基]-1H-咪唑硝酸鹽 | Sertaconazole nitrate; 1-[2-[(7-Chloro-1-benzothiophen-3-yl)methoxy]-2-(2,4-dichlorophenyl)ethyl]imidazole nitrate |  | C20H16Cl3N3O4S | 詳情 | 供應(yīng)商 |
| 99592-39-9 | 硝酸舍他康唑; 1-(2-((7-氯苯并(b)噻吩-3-基)甲氧基)-2-(2,4-二氯苯基)乙基)-1H-咪唑硝酸鹽 | Sertaconazole nitrate; 1-(2-((7-Chlorobenzo(b)thien-3-yl)methoxy)-2-(2,4-dichlorophenyl)ethyl)-1H-imidazole mononitrate |  | C20H16Cl3N3O4S | 詳情 | 供應(yīng)商 |
| 144143-96-4 | 甲磺酸依普羅沙坦; 4-[[2-丁基-5-(2-甲�；�-3-噻吩-2-基-丙烯-1-基)-咪唑-1-基]甲基]苯甲酸甲磺酸鹽 | Eprosartan mesylate; 4-[[2-Butyl-5-(2-carboxy-3-thiophen-2-yl-prop-1-enyl)-imidazol-1-yl]methyl]benzoic acid mesylate |  | C24H28N2O7S2 | 詳情 | 供應(yīng)商 |
| 104208-13-1 | 1,3-二甲基-2-(2-噻吩)咪唑烷 | Imidazolidine,1,3-dimethyl-2-(2-thienyl)-; 1,3-DIMETHYL-2-(2-THIENYL)IMIDAZOLIDINE; 1,3-Dimethyl-2-(2-thienyl)imidazoline; Dimethylthienylimidazoline; 1,3-Dimethyl-2-(2-thienyl)imidazolidine ,97% |  | C9H14N2S | 詳情 | 供應(yīng)商 |
| 31428-61-2 | 噻美尼定; 噻美尼定.; N-(2-氯-4-甲基-3-噻吩基)-4,5-二氫-1H-咪唑-2-胺 | 1H-Imidazol-2-amine,N-(2-chloro-4-methyl-3-thienyl)-4,5-dihydro-; 2-Imidazoline,2-[(2-chloro-4-methyl-3-thienyl)amino]- (8CI); NSC 351524; Symcor Base TTS; Thiamendidine; Tiamenidine |  | C8H10ClN3S | 詳情 | 供應(yīng)商 |
| 80168-44-1 | 鹽酸齊諾康唑; (E)-1-(5-氯-2-噻吩基-2-(1H)-咪唑-1-基)乙酮(2,6-二氯苯基)腙鹽酸鹽 | zinoconazole hydrochloride; E-851 |  | C15H11Cl3N4S·HCl | 詳情 | 供應(yīng)商 |
| 133040-01-4 | 依普沙坦; 依普沙坦; (E)- Α-[[2-丁基-1-[(4-羧基苯基)甲基]-1H-咪唑-5-基]亞甲基]-2-噻吩丙酸 | 2-Thiophenepropanoicacid, a-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-,(aE)-; 2-Thiophenepropanoicacid, a-[[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazol-5-yl]methylene]-,(E)-; (E)-2-Butyl-1-(p-carboxybenzyl)-a-2-thenylimidazole-5-acrylic acid; Eprosartan; SKB108566; SKF 108566; Teveten |  | C23H24N2O4S | 詳情 | 供應(yīng)商 |
| 62031-97-4 | 5-甲基-5-噻吩-2-咪唑烷-2,4-二酮 | 5-METHYL-5-THIEN-2-YLIMIDAZOLIDINE-2,4-DIONE; 5-Mmethyl-5-thien-2-ylimidazolidine-2,4-dione |  | C8H8N2O2S | 詳情 | 供應(yīng)商 |
| 660868-91-7 | 3-[2-(三氟甲基)芐氧基]-5-(5,6-二甲氧基-1H-苯并[D]咪唑-1-基)-2-噻吩甲酰胺; 3-[2-(三氟甲基)芐氧基]-5-(5 | GW843682, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-car; GW843682, 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide; GW843682X; 3-(2-(Trifluoromethyl)benzyloxy)-5-(5,6-dimethoxy-1H-benzo[d]imidazol-1-yl)thiophene-2-carboxamide; Polo-like Kinase Inhibitor III; 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-{[2-(trifluoromethyl)-benzyl]oxy}thiophene-2-carboxamide; 5-(5,6-Dimethoxy-1H-benzimidazol-1-yl)-3-[[2-(trifluoromethyl)phenyl]methoxy]-2-thiophenecarboxamide |  | C22H18F3N3O4S | 詳情 | 供應(yīng)商 |
| 127062-22-0 | 6-[[5-(六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-基)-1-氧代戊基]氨基]己酸 2,5-二氧代-3-磺酸-1-吡咯烷基酯鈉? | SULPHOSUCCINIMIDYL-6-(BIOTINAMIDO)HEXANOATE; SULPHO LC BIOTIN; SULPHOSUCCINIMIDYL-6-(BIOTINAMIDO)HEXANOATE; SULFOSUCCINIMIDYL N-(D-BIOTINYL)-6-AMINOHEXANOATE; biotinamidocaproicacid3-sulfo-n-*hydroxysuccini; BIOTINAMIDOCAPROIC ACID 3-SULFO-N-HYDROX YSUCCINIMI; biotinamidocaproic acid 3-sulfo-N-hydroxysuccinimide ester; 6-[[5-(Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl)-1-oxopentyl]amino]hexanoic acid 2,5-dioxo-3-sulfo-1-pyrrolidinyl ester sodium salt (1:1); 2'-Deoxy-5'-O-DMT-N6-methyl-8-oxoadenosine 3'-CE phosphoramidite |  | C20H30N4O9S2 | 詳情 | 供應(yīng)商 |
| 875337-44-3 | N-(3-氟-4-(2-(1-甲基-1H-咪唑-4-基)噻吩并[3,2-B]吡啶-7-氧基)苯基氨基硫代甲�；�)-2-苯乙酰胺; N-(3-氟-4- | N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phen; N-(3-fluoro-4-(2-(1-methyl-1H-imidazol-4-yl)thieno[3,2-b]pyridin-7-yloxy)phenylcarbamothioyl)-2-phenylacetamide; MGCD-265 (Synonyms MGCD265); MGCD-265 |  | C26H20FN5O2S2 | 詳情 | 供應(yīng)商 |
| 1190427-49-6 | "三環(huán)[1,3 -二(2,4,6三甲苯)咪唑- 2 -亞基] [2 -噻吩亞甲基] 二氯化釕 | Tricyclohexylphosphine[1,3-bis(2,4,6-trimethylphenyl)imidazol-2-ylidene] [2-thienylmethylene]rutheni | 無 | 詳情 | 供應(yīng)商 | |
| 929095-18-1 | 5-[6-[(4-甲基-1-哌嗪)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩羧胺; 5-[6-[(4-甲基-1-哌嗪)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩羧胺; GSK461364; 5-[6-[(4-甲基-1-哌嗪基)甲基]-1H-苯并咪唑-1-基]-3-[(1R)-1-[2-(三氟甲基)苯基]乙氧基]-2-噻吩甲酰胺 | 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide; 5-[6-[(4-methyl-1-piperazinyl)methyl]-1H-benzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-Thiophenecarboxamide; GSK-461364; (R)-5-(6-((4-methylpiperazin-1-yl)methyl)-1H-benzo[d]imidazol-1-yl)-3-(1-(2-(trifluoromethyl)phenyl)ethoxy)thiophene-2-carboxamide; GSK-461364A; GSK461364(GSK-461364) |  | C27H28F3N5O2S | 詳情 | 供應(yīng)商 |
| 945633-30-7 | (3AS,4S,6AR)-N-[2-[2-(2-疊氮乙氧基)乙氧基]乙基]六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-戊酰胺; (3AS,4S,6AR)-N-[2-[2-(2-疊氮乙氧基)乙氧基]乙基]六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-戊酰胺 | Biotin-PEG3-N3; Biotin-PEG3-N3; 1H-Thieno[3,4-d]imidazole-4-pentanamide,N-[2-[2-(2-azidoethoxy)ethoxy]ethyl]hexahydro-2-oxo-,(3aS,4S,6aR)-; Biotin-PEG3-azide; (+)-Biotin-PEG3- CH2CH2azide; (3aS,4S,6aR)-N-[2-[2-(2-Azidoethoxy)ethoxy]ethyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide | 無 | C16H28N6O4S | 詳情 | 供應(yīng)商 |
| 252881-76-8 | 18-[(3AS,4S,6AR)-六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-基]-14-氧代-4,7,10-三氧雜-13-氮雜十八烷酸; 18-[(3AS,4S,6AR)-六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-基]-14-氧代-4,7,10-三氧雜-13-氮雜十八烷酸 | Biotin-PEG3-propionic acid; Biotin-PEG3-propionic acid; 18-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-14-oxo-4,7,10-trioxa-13-azaoctadecanoic acid | 無 | C19H33N3O7S | 詳情 | 供應(yīng)商 |
| 721431-18-1 | 15-[D-(+)-生物素氨基]-4,7,10,13-四氧雜十五烷酸; 15-[D-(+)-生物素氨基]-4,7,10,13-四氧雜十五烷酸; 21-[(3AS,4S,6AR)-六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-基]-17-氧代-4,7,10,13-四氧雜-16-氮雜二十一烷酸 | 15-[D(+)-BIOTINYLAMINO]-4,7,10,13-TETRAOXAPENTADECANOIC ACID; 15-[D(+)-BIOTINYLAMINO]-4,7,10,13-TETRAOXAPENTADECANOIC ACID; Biotin-PEG4-propionic acid; (+)-Biotin-PEG4-CH2CH2COOH; 21-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-17-oxo-4,7,10,13-tetraoxa-16-azaheneicosanoic acid |  | C21H37N3O8S | 詳情 | 供應(yīng)商 |
| 596820-83-6 | N-[2-[2-[3-[(2,5-二氧代-1-吡咯烷基)氧基]-3-氧代丙氧基]乙氧基]乙基]六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-戊酰胺; N-[2-[2-[3-[(2,5-二氧代-1-吡咯烷基)氧基]-3-氧代丙氧基]乙氧基]乙基]六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-戊酰胺 | 9-biotinlaMino-4,7-dioxanonanoic acid N-hydroxysucciniMidyl ester; 9-biotinlaMino-4,7-dioxanonanoic acid N-hydroxysucciniMidyl ester; Biotin-PEG2-NHS; N-[2-[2-[3-[(2,5-Dioxo-1-pyrrolidinyl)oxy]-3-oxopropoxy]ethoxy]ethyl]hexahydro-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide | 無 | C21H32N4O8S | 詳情 | 供應(yīng)商 |
| 459426-22-3 | 21-[(3AS,4S,6AR)-六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-基]-17-氧代-4,7,10,13-四氧雜-16-氮雜二十一碳酸 2,5-二氧代-1-吡咯烷基酯; 21-[(3AS,4S,6AR)-六氫-2-氧代-1H-噻吩并[3,4-D]咪唑-4-基]-17-氧代-4,7,10,13-四氧雜-16-氮雜二十一碳酸 2,5-二氧代-1-吡咯烷基酯 | 15-biotinlaMino-4,7,10,13-dioxanonanoic acid N-hydroxysucciniMidyl ester; 15-biotinlaMino-4,7,10,13-dioxanonanoic acid N-hydroxysucciniMidyl ester; Biotin-PEG4-NHS; Biotin-PEG4-CH2CH2COONHS Ester; 21-[(3aS,4S,6aR)-Hexahydro-2-oxo-1H-thieno[3,4-d]imidazol-4-yl]-17-oxo-4,7,10,13-tetraoxa-16-azaheneicosanoic acid 2,5-dioxo-1-pyrrolidinyl ester | 無 | C25H40N4O10S | 詳情 | 供應(yīng)商 |
| 906099-89-6 | (3AS,4S,6AR)-六氫-N-(17-羥基-3,6,9,12,15-五氧雜十七烷-1-基)-2-氧代-1H-噻吩并[3,4-D]咪唑-4-戊酰胺; (3AS,4S,6AR)-六氫-N-(17-羥基-3,6,9,12,15-五氧雜十七烷-1-基)-2-氧代-1H-噻吩并[3,4-D]咪唑-4-戊酰胺 | Biotin-PEG6-OH; Biotin-PEG6-OH; (3aS,4S,6aR)-Hexahydro-N-(17-hydroxy-3,6,9,12,15-pentaoxaheptadec-1-yl)-2-oxo-1H-thieno[3,4-d]imidazole-4-pentanamide | 無 | C22H41N3O8S | 詳情 | 供應(yīng)商 |